Healthcare Sector

MRK

Market Tracker

$111.35
-0.95
(-0.85%)
2:40 pm
Next Earnings: (est.) 10/27/22 12:00 am
  • MRK (Selected)

    Merck & Co., Inc.
  • MRK#

    Merck & Co., Inc. (MRK
  • MRKR

    Marker Therapeutics, Inc.

MRK Support / Resistance Levels

Loading Data..
WhaleStream

15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.

MRK Most Active Options Strike Prices Whale BUY Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.

MRK Most Active Options Strike Prices Whale SALES Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.

MRK Dark Pool and Public Equity Key Price Levels

Loading Data..

Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.

MRK Open Interest Trend

Loading Data..

Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.

MRK Largest 1-Day Open Interest Movements

Expires Type Strike OI Change Percent
07/17/2026 PUT $110.00 11,830 +11,830
07/17/2026 CALL $110.00 11,830 +11,830
10/16/2026 CALL $130.00 2,138 +1,555 +266.72%
06/18/2026 CALL $120.00 9,663 +1,224 +14.50%
05/15/2026 CALL $111.00 730 +507 +227.35%
05/15/2026 PUT $113.00 1,818 +399 +28.12%
05/08/2026 PUT $118.00 113 -63 -35.80%
05/08/2026 CALL $117.00 664 -80 -10.75%
05/15/2026 PUT $120.00 8,620 -3,830 -30.76%
05/15/2026 CALL $120.00 8,620 -3,830 -30.76%
05/15/2026 CALL $115.00 4,522 -7,000 -60.75%
05/15/2026 PUT $115.00 4,500 -7,000 -60.87%

Contracts with largest changes in open interest from the previous trading day to the current/most recent.

MRK Major Holders

Name Pct Held Shares Total
Vanguard Total Stock Market Index Fund 2.94% 74.47M 6.53B
Vanguard 500 Index Fund 2.21% 55.97M 4.91B
SPDR S&P 500 ETF Trust 1.07% 27.12M 2.38B
Fidelity 500 Index Fund 1.06% 26.84M 2.35B
iShares Core S&P 500 ETF 0.88% 22.4M 1.96B
Vanguard Index-Value Index Fund 0.86% 21.87M 1.92B
Select Sector SPDR Fund-Health Care 0.80% 20.27M 1.78B
Vanguard Institutional Index Fund-Institutional Index Fund 0.74% 18.74M 1.64B
Schwab Strategic Tr-Schwab U.S. Dividend Equity ETF 0.72% 18.33M 1.61B
Vanguard Fenway Funds-Equity Income Fund 0.55% 13.84M 1.21B
Vanguard Specialized-Dividend Growth Fund 0.50% 12.76M 1.12B
MFS Series Trust I-MFS Value Fund 0.48% 12.13M 1.06B
Columbia Fds Ser Tr I-Columbia Dividend Income Fd 0.33% 8.45M 741.3M
Income Fund of America Inc 0.28% 7.05M 618.18M
Vanguard/Wellesley Income Fund 0.28% 7.12M 624.65M
Schwab Capital Trust-Schwab S&P 500 Index Fund 0.18% 4.58M 401.42M
Franklin Custodian Funds-Income Fund 0.18% 4.5M 394.74M
Invesco Diversified Dividend Fund 0.17% 4.33M 379.45M

MRK News

  • 2 Dividend Stocks to Double Up On Right Now

    05/08 01:30 pm

    The Motley Fool

    Read more
  • Immutrin appoints leading cardiovascular drug development expert Dr. Robert Blaustein as Chief Medical Officer and establishes US subsidiary

    05/06 07:00 am

    GlobeNewswire Inc.

    Read more
  • InVitria Showcases Exbumin® and Optibumin® 25 at IPEC Excipient World: Biologics Summit: Recombinant Human Serum Albumins Already Used in On-Market Approved Biologics

    05/01 08:00 am

    GlobeNewswire Inc.

    Read more
  • Merck Swings To Quarterly Loss On Cidara Deal

    04/30 01:10 pm

    Benzinga

    Read more
  • Bulk Filtration Market Report 2026, Competitive Analysis of 3M, Eaton, Parker-Hannifin, Pentair, Merck, Danaher, Mann+Hummel - Analyst Recommendations and Global Forecast to 2031

    04/28 10:00 am

    GlobeNewswire Inc.

    Read more
  • Antibiotic Resistance Market to Grow at 5.4% CAGR Reaching USD 12.72 Billion by 2031, Driven by Rising Drug-Resistant Infections and Antimicrobial Innovation: Mordor Intelligence

    04/28 03:52 am

    GlobeNewswire Inc.

    Read more
  • Stock Market Today, April 27: Organon Shares Surge After Sun Pharma Agrees to Acquire Company in All Cash Deal

    04/27 05:34 pm

    The Motley Fool

    Read more
  • AI Disruption in Lung Cancer Therapeutics Set to Transform Treatment Paradigms as Billion-Dollar Investments Drive Innovation

    04/27 01:36 pm

    GlobeNewswire Inc.

    Read more
  • Peripheral T-Cell Lymphoma Market to Witness Significant Expansion at a CAGR of 7% During the Forecast Period (2026–2036) Amid Advancing Treatment Landscape | DelveInsight

    04/27 01:00 pm

    GlobeNewswire Inc.

    Read more
  • 3 Biotech Stocks That Could Benefit from the Patent Cliff

    04/27 11:29 am

    Investing.com

    Read more
  • Large Drugmakers Eye Inhibrx Cancer Drugs Valued Over $8 Billion, Stock Surges

    04/22 02:20 pm

    Benzinga

    Read more
  • Polycythemia Vera Market Set for Transformation: Key 9 Companies Expected to Enter by 2036 | DelveInsight

    04/22 01:00 pm

    GlobeNewswire Inc.

    Read more
  • Vulvar Cancer Market Global and Regional Analysis Report 2025-2035, Profiles of Merck & Co., Bristol Myers Squibb, and AstraZeneca

    04/22 05:59 am

    GlobeNewswire Inc.

    Read more
  • Why Is Merck Stock Falling Tuesday?

    04/21 01:42 pm

    Benzinga

    Read more
  • Follicular Lymphoma Clinical Trial Space Intensifies with 45+ Companies in Active Development | DelveInsight

    04/21 01:00 pm

    GlobeNewswire Inc.

    Read more
  • Oncolytic Virus Immunotherapy Market Landscape Report 2026: A $5 Opportunity by 2031 - Technology Platforms, Approved Therapy Dosage, Price & Clinical Trials Insights

    04/21 04:14 am

    GlobeNewswire Inc.

    Read more
  • Pheochromocytoma and Paraganglioma Market to Exhibit Growth at 7.3% CAGR by 2036 Driven by the Advent of Drug Classes Such as SSTR2 analogs, Dopamine Receptor D2 Agonists, TAAs or TSAs, and Others | DelveInsight

    04/20 01:00 pm

    GlobeNewswire Inc.

    Read more
  • Better Pharma Dividend Stock: Novartis vs. Merck

    04/17 02:37 pm

    The Motley Fool

    Read more
  • Non-Small Cell Lung Cancer Clinical Trial Race Intensifies as 100+ Companies Competing in Therapeutic Segment Worldwide | DelveInsight

    04/16 01:00 pm

    GlobeNewswire Inc.

    Read more
  • Immutep Receives FDA Orphan Drug Designation for Eftilagimod Alfa in Soft Tissue Sarcoma

    04/15 08:00 am

    GlobeNewswire Inc.

    Read more
  • Mestag Therapeutics Selected to Present Targeted LTBR Agonist MST‑0312 in Late‑Breaking Session at AACR Annual Meeting

    04/14 03:30 am

    GlobeNewswire Inc.

    Read more
  • Revolution Medicines Rallies After Phase 3 Pancreatic Cancer Trial Doubles Survival Versus Chemo

    04/13 10:10 am

    Benzinga

    Read more
  • $5.14 Bn Castration-sensitive Prostate Cancer Market Insights, Epidemiology, and Forecasts, 2022-2026 & 2026-2036

    04/13 04:44 am

    GlobeNewswire Inc.

    Read more
  • Epitopea renforce son comité consultatif scientifique avec la nomination de Lisa Butterfield, figure de renom dans le domaine du cancer

    04/13 04:00 am

    GlobeNewswire Inc.

    Read more
  • Which Dividend Pharma Stock Should a Value Investor Choose Today?

    04/12 08:28 pm

    The Motley Fool

    Read more
  • Sun Pharma Nears Final Offer For Organon In Largest Overseas Bet

    04/10 10:57 am

    Benzinga

    Read more
  • Crohn's Disease Eight-Market Drug Forecast and Market Analysis Report 2025-2026: Novel MOAs Will Provide Market Shifts Throughout the Forecast Period to 2032

    04/10 04:43 am

    GlobeNewswire Inc.

    Read more
  • Merck Lowered Terns Pharmaceuticals Offer Price After Trial Data Review

    04/07 02:28 pm

    Benzinga

    Read more
  • What's Going On With Merck Stock Tuesday?

    04/07 12:46 pm

    Benzinga

    Read more
  • Evaxion announces last patient visit in one-year extension of phase 2 trial with personalized cancer vaccine EVX-01

    04/07 08:00 am

    GlobeNewswire Inc.

    Read more
  • Merck Just Made a Big Bet on a New Cancer Growth Engine

    04/02 11:32 am

    Investing.com

    Read more
  • Adagene Reports Full Year 2025 Financial Results and Provides Corporate Update

    04/01 05:00 pm

    GlobeNewswire Inc.

    Read more
  • Merck Locks Infinimmune Alliance To Chase Next-Gen Antibody Drugs

    04/01 09:26 am

    Benzinga

    Read more
  • This Top ETF Recently Added a Healthy Dose of These High-Yielding Dividend Stocks

    03/30 06:30 am

    The Motley Fool

    Read more
  • Esophageal Cancer Market to Grow from $1.65 Billion in 2026 to $2.37 Billion by 2030: Pfizer, Roche, Merck & Co. Dominate

    03/30 05:00 am

    GlobeNewswire Inc.

    Read more
  • Merck's $6.7 Billion Terns Pharmaceuticals Acquisition May Face Rival Interest: Analyst

    03/25 11:20 am

    Benzinga

    Read more
  • Merck to Acquire Terns Pharmaceuticals, Inc., Expanding Its Hematology Pipeline With TERN-701, a Novel Candidate for Chronic Myeloid Leukemia (CML)

    03/25 06:48 am

    Benzinga

    Read more
  • Merck Nears $6 Billion Deal To Buy Terns Pharma: Report

    03/25 05:38 am

    Benzinga

    Read more
  • Quotient Therapeutics Announces Collaboration with Merck to Discover Novel Drug Targets in Inflammatory Bowel Disease Using Somatic Genomics Platform Technology

    03/24 06:00 am

    GlobeNewswire Inc.

    Read more
  • ELISpot & FluoroSpot Assay Market Report 2026-2031: Mabtech, Oxford Immunotec Global, and Cellular Technology Dominate the Landscape

    03/20 07:00 am

    GlobeNewswire Inc.

    Read more
  • Pfizer vs Moderna: Which Pharma Stock Has More Upside?

    03/19 03:30 pm

    The Motley Fool

    Read more
  • Unnatural Products Raises $45 Million Series B Financing to Advance Macrocyclic Peptide Therapeutics

    03/16 07:00 am

    GlobeNewswire Inc.

    Read more
  • Zostavax Market Research Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts, 2020-2025, 2025-2030F, 2035F

    03/09 10:59 am

    GlobeNewswire Inc.

    Read more
  • Rotateq Market Research Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts, 2020-2025, 2025-2030F, 2035F

    03/09 10:54 am

    GlobeNewswire Inc.

    Read more
  • 1 Dividend Stock to Buy Hand Over Fist and 1 to Avoid

    03/08 01:30 pm

    The Motley Fool

    Read more
  • Cytokines Market Global Forecast 2026-2032: Precise Treatments, Strategic Partnerships, and Supply Chain Resilience Fueling the $95+ Billion Market

    03/05 05:44 am

    GlobeNewswire Inc.

    Read more
  • AI-Powered Tempus Inks New Multi-Year Merck Deal

    03/03 03:33 pm

    Benzinga

    Read more
  • MXene Industry Research Report 2026: Market to Grow at a CAGR of 35.6% to 2032, Driven by EV & Charging Infrastructure, Water Treatment Applications and High-Performance Aerospace & Defense Systems

    03/03 05:53 am

    GlobeNewswire Inc.

    Read more
  • Antibiotics Market - 4.07% CAGR Forecast for 2026-2031 as Antimicrobial Innovation Strengthens Demand, Says Mordor Intelligence

    03/02 05:59 am

    GlobeNewswire Inc.

    Read more
👀

Follow the Whales in real-time.

🎁

Take 50% OFF With Code: